Metabotrophic glutamate receptor 5 modulators and methods use thereof
Compounds that modulate GluR5 activity and methods of using the same are disclosed.
1. A compound, wherein said compound is:
or a pharmaceutically acceptable salt thereof.
2. The compound according to claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt thereof.
3. The compound according to claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt thereof.
4. A method of treating Fragile X, comprising the step of administering the compound:
or a pharmaceutically acceptable salt thereof, to a patient or subject in need thereof.
5. The method according to claim 4 , wherein said compound is:
or a pharmaceutically acceptable salt thereof.
6. The method according to claim 4 , wherein said compound is:
or a pharmaceutically acceptable salt thereof.